Cardinal Health (NYSE:CAH) has secured exclusive North American marketing rights for a recently cleared staph-infection blood test from diagnostics company MicroPhage.In exchange, Dublin, Ohio-based Cardinal has provided MicroPhage with an unspecified amount of operational funding for development and commercialization of new products, according to a statement from MicroPhage.Reached by phone, MicroPhage officials declined to specify [...]

While just a small part of Cardinal Health‘s (NYSE:CAH) $100 billion-plus revenue, the nuclear medicine business is an important driver of higher margins for the drug distribution company.In particular, positron emission tomography (PET) radiopharmaceuticals — which are used to aid in imaging scans for cancer, heart disease and brain disorders — are poised to be [...]

Cardinal Health (NYSE:CAH) sees a big growth opportunity in the specialty drugs distribution market, but catching up with its top two rivals could be a tough slog.Specialty drugs are typically complex, injectable biologics that are used to treat somewhat small groups of patients for specific conditions like multiple sclerosis, cystic fibrosis and certain types of [...]

Drug distributor Cardinal Health (NYSE: CAH) reported a 19 percent fourth-quarter increase in sales of generic drugs, an area that continues to be a strength for the company.Generics — as well as acquisitions that have allowed the company to sell more generics — contributed to a 9 percent increase in fourth-quarter revenue to $26.8 billion, [...]

Pharmaceuticals distributor Cardinal Health (NYSE: CAH) has opened a molecular imaging center with the goal of developing new radioactive imaging agents that will help doctors treat a wide range of diseases like cancer, heart disease and neurological disorders.Cardinal scientists, engineers and manufacturing experts will work with clients in the pharmaceutical and academic research industries at [...]

Once an early high-profile supporter of the medical mart concept, drug distributor Cardinal Health (NYSE:CAH) has had an apparent change of opinion.The giant drug distributor – and Ohio’s largest company – does not plan to lease space in the planned Cleveland medical mart or its counterpart in Nashville, spokeswoman Corey Kerr said. So don’t expect [...]

The capital punishment-opposing nun prominently featured in the movie “Dead Man Walking” has asked Cardinal Health (NYSE: CAH) to recall a drug that’s used in the execution of prisoners.But Sister Helen Prejean isn’t likely to be pleased with the response from the Dublin, Ohio-based pharmaceuticals distributor. A Cardinal spokeswoman was asked multiple times whether the [...]

Medical products supplier Cardinal Health (NYSE:CAH) raised its full-year earnings expectations, driven in part by a 25 percent increase in third-quarter profits in its pharmaceutical business.Dublin, Ohio-based Cardinal now expects adjusted full-year earnings per share from continuing operations between $2.61 and $2.67, according to a statement from the company. CEO George Barrett cited strong year-to-date [...]

After a little more than a year on the job, a Cardinal Health (NYSE:CAH) board member is stepping down for health reasons.Dr. James Mongan’s resignation comes “due to health-related reasons,” and “is not the result of any disagreement with [Cardinal] on any matter relating to the [its] operations, policies or practices,” according to a regulatory [...]

Cardinal Health (NYSE:CAH) and pharmaceuticals distributors of its ilk will have few better friends over the coming years than generic drugs.The so-called “generic wave” — created by scores of brand-name drugs whose patents are expiring between this year and 2015 — is expected to be a huge boon to drug wholesalers like Dublin, Ohio-based Cardinal, [...]